{
  "actions": [
    {
      "acted_at": "2018-06-19", 
      "action_code": "Intro-H", 
      "references": [], 
      "text": "Introduced in House", 
      "type": "action"
    }, 
    {
      "acted_at": "2018-06-19", 
      "action_code": "H11100", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the House Committee on Energy and Commerce.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr6133-115", 
  "bill_type": "hr", 
  "by_request": false, 
  "committee_reports": [], 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }
  ], 
  "congress": "115", 
  "cosponsors": [], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2018-06-19", 
  "number": "6133", 
  "official_title": "To deter opioid abuse and addiction through the development of high-quality, evidence-based opioid analgesic prescribing guidelines, and for other purposes.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "hr6-115", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }
  ], 
  "short_title": "Informing Opioid Prescribing Through Evidence-Based Guidelines Act of 2018", 
  "sponsor": {
    "bioguide_id": "M001187", 
    "district": "11", 
    "name": "Meadows, Mark", 
    "state": "NC", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2018-06-19", 
  "subjects": [
    "Administrative law and regulatory procedures", 
    "Congressional oversight", 
    "Department of Health and Human Services", 
    "Drug safety, medical device, and laboratory regulation", 
    "Drug therapy", 
    "Drug trafficking and controlled substances", 
    "Food and Drug Administration (FDA)", 
    "Government studies and investigations", 
    "Health", 
    "Health care costs and insurance", 
    "Health care coverage and access", 
    "Health promotion and preventive care", 
    "Prescription drugs", 
    "Public participation and lobbying", 
    "Retail and wholesale trades"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced in House", 
    "date": "2018-06-19T04:00:00Z", 
    "text": "Informing Opioid Prescribing Through Evidence-Based Guidelines Act of 2018\n\nThis bill requires the Food and Drug Administration to develop evidence-based opioid prescribing guidelines for certain acute pain treatment."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To deter opioid abuse and addiction through the development of high-quality, evidence-based opioid analgesic prescribing guidelines, and for other purposes.", 
      "type": "official"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Informing Opioid Prescribing Through Evidence-Based Guidelines Act of 2018", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Informing Opioid Prescribing Through Evidence-Based Guidelines Act of 2018", 
      "type": "short"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "Informing Opioid Prescribing Through Evidence-Based Guidelines Act of 2018", 
      "type": "display"
    }
  ], 
  "updated_at": "2019-07-16T21:20:08Z", 
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/115/hr/BILLSTATUS-115hr6133.xml"
}